Updated Nov. 3, 2011 at 6:54 a.m.
Andrew Witty
Image 1 of 2 · Next Image…
The case dates from 2004, and includes investigations of possible price irregularities and the development and marketing of the diabetes drug Avandia. One analyst says the deal removes "uncertainty" about "ongoing legal issues."...Copyright 2013 WRAL Tech Wire and the Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
GSK to pay US $3B to settle probes of sales, marketing
Post a comment
Print this blog postE-mail blog post
Share
Andrew Witty
Image 1 of 2 · Next Image…
The case dates from 2004, and includes investigations of possible price irregularities and the development and marketing of the diabetes drug Avandia. One analyst says the deal removes "uncertainty" about "ongoing legal issues."...Copyright 2013 WRAL Tech Wire and the Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
IBM layoff update: North American cuts climb; mum is word down under- At last! Sprint 4G service formally launches in Triangle
- Big Blue's layoff total climbs in RTP; North America total surges past 2,800
- Big Blue layoff count nears 2,800 in North America alone
- NC's high-tech job picture improves in May, but ...
- IBM layoff count hits nearly 2,300 across 31 work groups
- NC IDEA: Startup deal flow 'better than it has ever been'
- IBM's job cuts are global, nearing 4,000; most are in U.S.
- CEO fears for future of NC Biofuels Center due to budget cuts
- Workers 50+ take biggest hit among 14% reduction in IBM marketing group